FIELD: heterocyclic compounds. SUBSTANCE: invention relates to heterocyclic compounds showing activity of 5-$$$-receptor antagonist. Product: condensed indole derivative of the formula (I): $$$ where X - O; A - $$$; $$$ - hydrogen; Y - NH; Z means group of the formula: $$$ where $$$ means hydrogen, $$$-alkyl, phenyl-$$$-alkyl or $$$ - $$$ where z = 2 or 3, and $$$ is taken from phenoxy and $$$ where $$$ and $$$ - hydrogen or $$$-alkyl, or its pharmaceutically acceptable salt and pharmaceutical composition showing activity of 5-$$$-receptor antagonist and containing compound of the formula (I) at effective amount. EFFECT: improved method of synthesis, enhanced effectiveness of composition. 4 cl, 2 tbl
Title |
Year |
Author |
Number |
HETEROCYCLIC COMPOUNDS AS ANTAGONISTS OF 5-HT RECEPTORS, METHOD OF SYNTHESIS, PHARMACEUTICAL COMPOSITION |
1992 |
- Frehnsis Dehvid King
- Ljarami Mari Gaster
- Kit Rajmond Malkholland
- Shirli Katrin Rakhman
- Pol' Adrian Viman
- Gehret Dzhon Zangen
- Kej Alison Uordl
- Gordon Smit Bakster
- Gaj Ehntoni Kennet
- Al'Berto Khulio Kauman
|
RU2124512C1 |
6-(SUBSTITUTED METHYLENE)PENEMS, METHOD OF PREPARING THEREOF, INTERMEDIATE PRODUCTS, AND PHARMACEUTICAL COMPOSITION |
1993 |
- Najdzhel Dzhon Perrimen Brum
- Frehnk Peter Kharrington
|
RU2133750C1 |
METHOD OF EPOXIDATION OF PROCHIRAL OLEFIN |
1995 |
- Bell Dehvid
- Finnej Frantsiska
- Attrill Robin Patrik
- Miller Dehvid
- Terner Dzhillian
|
RU2204562C2 |
ANTAGONISTS OF ENDOTHELIAL RECEPTORS, PHARMACEUTICAL COMPOSITION, METHOD OF SYNTHESIS, METHOD OF INHIBITION OF ENDOTHELIAL RECEPTORS |
1992 |
- Rassell Donovan Kaznz
- Dzhon Dunkan Ehlliott
- Marija Amparo Lago
- Dzhek Dejl Liber
- Kehtrin Ehlizabet Pejshoff
|
RU2125980C1 |
HETEROCYCLIC COMPOUND OR ITS TAUTOMERIC FORM AND/OR PHARMACEUTICALLY ACCEPTABLE SALT AND/OR PHARMACEUTICALLY ACCEPTABLE SOLVATE, PHARMACEUTICAL COMPOSITION DECREASING BLOOD GLUCOSE LEVEL, METHOD OF TREATMENT AND/OR PROPHYLAXIS OF HYPOGLYCEMIC PATIENTS |
1993 |
- Dehvid Khej
- Dzhon Tomas Sajm
|
RU2134686C1 |
METHOD OF TREATMENT OF STATE WHERE 5HT-LIKE AGONIST, DERIVATIVE OF TETRAHYDROCARBAZOLE IS REQUIRED, METHOD OF ITS SYNTHESIS, PHARMACEUTICAL COMPOSITION SHOWING ACTIVITY OF AGONIST OF 5HT-LIKE RECEPTORS |
1992 |
- Frehnsis Dehvid King
- Larami Mehri Gehster
- Al'Berto Dzhulio Kaumann
- Rodni Kristofer Jang
|
RU2137474C1 |
METHOD OF PREPARING AND/OR PURIFYING CLAVULANIC ACID OR PHARMACEUTICALLY ACCEPTABLE SALTS OR ESTERS THEREOF CLAVULANIC ACID SALT WITH AMINO ACID |
1993 |
- Majkl Allen Kuk[Gb]
- Robert Bennett Uilkins[Gb]
|
RU2105768C1 |
BENZOPYRANS, PHARMACEUTICAL COMPOSITION BASED THEREON, AND METHOD OF MEDICAL TREATMENT |
1995 |
- Vaj Ngor Chan
- Ehlen Kejt Ehnn Morgan
- Mervin Tompson
- Dzhon Morris Ehvans
|
RU2147581C1 |
METHOD OF SYNTHESIS OF CLAVULANIC ACID OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS AND ETHERS, CLAVULANIC ACID SALT WITH AMINE |
1995 |
- Majkl Allen Kuk[Gb]
- Robert Bennett Uilkins[Gb]
|
RU2081121C1 |
METHOD OF PREPARING CLAVULANIC ACID OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS OR ESTERS |
1995 |
- Majkl Allen Kuk[Gb]
- Robert Bennett Uilkins[Gb]
|
RU2088586C1 |